Clinical Trial Update: Efficacy Heterogeneity of Lactobacillus Paracasei LC19 on Type 2 Diabetes [NA]

View source ↗

Summary

A clinical trial is evaluating the efficacy heterogeneity of the probiotic Lactobacillus paracasei LC19 for Type 2 diabetes mellitus. The study is currently not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Lactobacillus paracasei LC19 (Lactobacillus paracasei LC19)

Snippet

Sponsor: Beijing Chao Yang Hospital | Conditions: Type 2 Diabetes | NA | Status: NOT_YET_RECRUITING